HEADER MEMBRANE PROTEIN 14-MAY-08 3D4S TITLE CHOLESTEROL BOUND FORM OF HUMAN BETA2 ADRENERGIC RECEPTOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2 ADRENERGIC RECEPTOR/T4-LYSOZYME CHIMERA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-2 ADRENOCEPTOR, BETA-2 ADRENORECEPTOR / LYSIS PROTEIN, COMPND 5 MURAMIDASE, ENDOLYSIN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_TAXID: 9606, 10665; SOURCE 4 GENE: ADRB2, ADRB2R, B2AR / E; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS GPCR, MEMBRANE PROTEIN, LYSOZYME, FUSION, ADRENERGIC, TIMOLOL, G- KEYWDS 2 PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, KEYWDS 3 PHOSPHOPROTEIN, RECEPTOR, TRANSDUCER, TRANSMEMBRANE, STRUCTURAL KEYWDS 4 GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ACCELERATED KEYWDS 5 TECHNOLOGIES CENTER FOR GENE TO 3D STRUCTURE, ATCG3D, GPCR NETWORK EXPDTA X-RAY DIFFRACTION AUTHOR M.A.HANSON,V.CHEREZOV,C.B.ROTH,M.T.GRIFFITH,V.-P.JAAKOLA,E.Y.T.CHIEN, AUTHOR 2 J.VELASQUEZ,P.KUHN,R.C.STEVENS,ACCELERATED TECHNOLOGIES CENTER FOR AUTHOR 3 GENE TO 3D STRUCTURE (ATCG3D),GPCR NETWORK (GPCR) REVDAT 11 30-OCT-24 3D4S 1 REMARK REVDAT 10 30-AUG-23 3D4S 1 REMARK REVDAT 9 20-OCT-21 3D4S 1 REMARK SEQADV REVDAT 8 24-JAN-18 3D4S 1 AUTHOR REVDAT 7 05-JUL-17 3D4S 1 SOURCE REVDAT 6 24-JUN-15 3D4S 1 JRNL SOURCE REMARK REVDAT 5 08-AUG-12 3D4S 1 REMARK VERSN REVDAT 4 01-SEP-09 3D4S 1 AUTHOR KEYWDS TITLE REMARK REVDAT 3 24-FEB-09 3D4S 1 VERSN REVDAT 2 01-JUL-08 3D4S 1 JRNL REVDAT 1 17-JUN-08 3D4S 0 JRNL AUTH M.A.HANSON,V.CHEREZOV,M.T.GRIFFITH,C.B.ROTH,V.P.JAAKOLA, JRNL AUTH 2 E.Y.CHIEN,J.VELASQUEZ,P.KUHN,R.C.STEVENS JRNL TITL A SPECIFIC CHOLESTEROL BINDING SITE IS ESTABLISHED BY THE JRNL TITL 2 2.8 A STRUCTURE OF THE HUMAN BETA2-ADRENERGIC RECEPTOR. JRNL REF STRUCTURE V. 16 897 2008 JRNL REFN ISSN 0969-2126 JRNL PMID 18547522 JRNL DOI 10.1016/J.STR.2008.05.001 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12782 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.0000 - 2.8000 0.01 0 121 0.3000 0.3800 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NUMBER OF TLS GROUPS WAS 2 IN REMARK 3 REFINEMENT. REMARK 4 REMARK 4 3D4S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047591. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-07; 11-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 77; NULL REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 9 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 23-ID-D; 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03324; 1.03324 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL; DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS; MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD; MARMOSAIC REMARK 200 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13598 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.14300 REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.57000 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2RH1 REMARK 200 REMARK 200 REMARK: THIS ENTRY IS A JCIMPT/ATCG3D STRUCTURE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% V/V PEG 400, 300MM K FORMATE, REMARK 280 100MM BIS-TRIS PROPANE PH 7.0, 2MM TIMOLOL, MESOPHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.36500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.85000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.36500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.85000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASN A 15 REMARK 465 ARG A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 HIS A 22 REMARK 465 ASP A 23 REMARK 465 VAL A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 GLU A 30 REMARK 465 VAL A 31 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 HIS A 349 REMARK 465 HIS A 350 REMARK 465 HIS A 351 REMARK 465 HIS A 352 REMARK 465 HIS A 353 REMARK 465 HIS A 354 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 100 30.01 -99.47 REMARK 500 PHE A 208 -53.89 -121.83 REMARK 500 ASN A1002 -161.52 -112.17 REMARK 500 ASP A1020 -168.36 -73.67 REMARK 500 ILE A1029 74.82 -102.06 REMARK 500 ARG A1125 75.30 -101.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TIM A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLC A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLC A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLC A 406 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RH1 RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN B2-ADRENERGIC G PROTEIN- REMARK 900 COUPLED RECEPTOR REMARK 900 RELATED ID: ATCG3D-ATCG3D_18 RELATED DB: TARGETTRACK REMARK 900 RELATED ID: GPCR-15 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE STRUCTURE IS AN INTERNAL FUSION PROTEIN WITH REMARK 999 LYSOZYME. AN OFFSET 1000 HAS BEEN ADDED TO ORIGINAL REMARK 999 SEQUENCE DATABASE RESIDUE NUMBERS (2-161) OF THE LYSOZYME REMARK 999 PART IN COORDINATES TO DISTINGUISH THE LYSOZYME PART IN THE REMARK 999 CHAIN. THEREFORE THE RESIDUES OF LYSOZYME PART HAVE NUMBERS REMARK 999 A1002-A1161. DBREF 3D4S A 1 230 UNP P07550 ADRB2_HUMAN 1 230 DBREF 3D4S A 1002 1161 UNP P00720 LYS_BPT4 2 161 DBREF 3D4S A 263 348 UNP P07550 ADRB2_HUMAN 263 348 SEQADV 3D4S ASP A -7 UNP P07550 EXPRESSION TAG SEQADV 3D4S TYR A -6 UNP P07550 EXPRESSION TAG SEQADV 3D4S LYS A -5 UNP P07550 EXPRESSION TAG SEQADV 3D4S ASP A -4 UNP P07550 EXPRESSION TAG SEQADV 3D4S ASP A -3 UNP P07550 EXPRESSION TAG SEQADV 3D4S ASP A -2 UNP P07550 EXPRESSION TAG SEQADV 3D4S ASP A -1 UNP P07550 EXPRESSION TAG SEQADV 3D4S ALA A 0 UNP P07550 EXPRESSION TAG SEQADV 3D4S TRP A 122 UNP P07550 GLU 122 ENGINEERED MUTATION SEQADV 3D4S GLU A 187 UNP P07550 ASN 187 ENGINEERED MUTATION SEQADV 3D4S THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 3D4S ALA A 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 3D4S HIS A 349 UNP P07550 EXPRESSION TAG SEQADV 3D4S HIS A 350 UNP P07550 EXPRESSION TAG SEQADV 3D4S HIS A 351 UNP P07550 EXPRESSION TAG SEQADV 3D4S HIS A 352 UNP P07550 EXPRESSION TAG SEQADV 3D4S HIS A 353 UNP P07550 EXPRESSION TAG SEQADV 3D4S HIS A 354 UNP P07550 EXPRESSION TAG SEQRES 1 A 490 ASP TYR LYS ASP ASP ASP ASP ALA MET GLY GLN PRO GLY SEQRES 2 A 490 ASN GLY SER ALA PHE LEU LEU ALA PRO ASN ARG SER HIS SEQRES 3 A 490 ALA PRO ASP HIS ASP VAL THR GLN GLN ARG ASP GLU VAL SEQRES 4 A 490 TRP VAL VAL GLY MET GLY ILE VAL MET SER LEU ILE VAL SEQRES 5 A 490 LEU ALA ILE VAL PHE GLY ASN VAL LEU VAL ILE THR ALA SEQRES 6 A 490 ILE ALA LYS PHE GLU ARG LEU GLN THR VAL THR ASN TYR SEQRES 7 A 490 PHE ILE THR SER LEU ALA CYS ALA ASP LEU VAL MET GLY SEQRES 8 A 490 LEU ALA VAL VAL PRO PHE GLY ALA ALA HIS ILE LEU MET SEQRES 9 A 490 LYS MET TRP THR PHE GLY ASN PHE TRP CYS GLU PHE TRP SEQRES 10 A 490 THR SER ILE ASP VAL LEU CYS VAL THR ALA SER ILE TRP SEQRES 11 A 490 THR LEU CYS VAL ILE ALA VAL ASP ARG TYR PHE ALA ILE SEQRES 12 A 490 THR SER PRO PHE LYS TYR GLN SER LEU LEU THR LYS ASN SEQRES 13 A 490 LYS ALA ARG VAL ILE ILE LEU MET VAL TRP ILE VAL SER SEQRES 14 A 490 GLY LEU THR SER PHE LEU PRO ILE GLN MET HIS TRP TYR SEQRES 15 A 490 ARG ALA THR HIS GLN GLU ALA ILE ASN CYS TYR ALA GLU SEQRES 16 A 490 GLU THR CYS CYS ASP PHE PHE THR ASN GLN ALA TYR ALA SEQRES 17 A 490 ILE ALA SER SER ILE VAL SER PHE TYR VAL PRO LEU VAL SEQRES 18 A 490 ILE MET VAL PHE VAL TYR SER ARG VAL PHE GLN GLU ALA SEQRES 19 A 490 LYS ARG GLN LEU ASN ILE PHE GLU MET LEU ARG ILE ASP SEQRES 20 A 490 GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY SEQRES 21 A 490 TYR TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER SEQRES 22 A 490 PRO SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA SEQRES 23 A 490 ILE GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU SEQRES 24 A 490 ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL SEQRES 25 A 490 ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR SEQRES 26 A 490 ASP SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN SEQRES 27 A 490 MET VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE SEQRES 28 A 490 THR ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP SEQRES 29 A 490 GLU ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN SEQRES 30 A 490 GLN THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE SEQRES 31 A 490 ARG THR GLY THR TRP ASP ALA TYR LYS PHE CYS LEU LYS SEQRES 32 A 490 GLU HIS LYS ALA LEU LYS THR LEU GLY ILE ILE MET GLY SEQRES 33 A 490 THR PHE THR LEU CYS TRP LEU PRO PHE PHE ILE VAL ASN SEQRES 34 A 490 ILE VAL HIS VAL ILE GLN ASP ASN LEU ILE ARG LYS GLU SEQRES 35 A 490 VAL TYR ILE LEU LEU ASN TRP ILE GLY TYR VAL ASN SER SEQRES 36 A 490 GLY PHE ASN PRO LEU ILE TYR CYS ARG SER PRO ASP PHE SEQRES 37 A 490 ARG ILE ALA PHE GLN GLU LEU LEU CYS LEU ARG ARG SER SEQRES 38 A 490 SER LEU LYS HIS HIS HIS HIS HIS HIS HET TIM A 401 21 HET CLR A 402 28 HET CLR A 403 28 HET OLC A 404 25 HET OLC A 405 25 HET OLC A 406 25 HETNAM TIM (2S)-1-(TERT-BUTYLAMINO)-3-[(4-MORPHOLIN-4-YL-1,2,5- HETNAM 2 TIM THIADIAZOL-3-YL)OXY]PROPAN-2-OL HETNAM CLR CHOLESTEROL HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETSYN TIM TIMOLOL MALEATE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 TIM C13 H24 N4 O3 S FORMUL 3 CLR 2(C27 H46 O) FORMUL 5 OLC 3(C21 H40 O4) FORMUL 8 HOH *20(H2 O) HELIX 1 1 TRP A 32 PHE A 61 1 30 HELIX 2 2 GLU A 62 GLN A 65 5 4 HELIX 3 3 THR A 66 VAL A 86 1 21 HELIX 4 4 VAL A 86 MET A 96 1 11 HELIX 5 5 PHE A 101 SER A 137 1 37 HELIX 6 6 THR A 146 MET A 171 1 26 HELIX 7 7 HIS A 178 GLU A 187 1 10 HELIX 8 8 ASN A 196 PHE A 208 1 13 HELIX 9 9 PHE A 208 LEU A 230 1 23 HELIX 10 10 ASN A 1002 GLY A 1012 1 11 HELIX 11 11 SER A 1038 GLY A 1051 1 14 HELIX 12 12 THR A 1059 ASN A 1081 1 23 HELIX 13 13 LEU A 1084 LEU A 1091 1 8 HELIX 14 14 ASP A 1092 GLY A 1107 1 16 HELIX 15 15 GLY A 1107 ALA A 1112 1 6 HELIX 16 16 PHE A 1114 GLN A 1123 1 10 HELIX 17 17 ARG A 1125 LYS A 1135 1 11 HELIX 18 18 SER A 1136 THR A 1142 1 7 HELIX 19 19 THR A 1142 GLY A 1156 1 15 HELIX 20 20 LEU A 266 GLN A 299 1 34 HELIX 21 21 ARG A 304 VAL A 317 1 14 HELIX 22 22 ASN A 318 GLY A 320 5 3 HELIX 23 23 PHE A 321 TYR A 326 1 6 HELIX 24 24 SER A 329 LEU A 340 1 12 SHEET 1 A 3 ARG A1014 LYS A1019 0 SHEET 2 A 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 A 3 HIS A1031 THR A1034 -1 O HIS A1031 N ILE A1027 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.03 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.04 SITE 1 AC1 12 THR A 110 ASP A 113 VAL A 114 VAL A 117 SITE 2 AC1 12 THR A 118 TYR A 199 SER A 203 TRP A 286 SITE 3 AC1 12 PHE A 290 ASN A 293 ASN A 312 TYR A 316 SITE 1 AC2 5 TYR A 70 THR A 73 CYS A 77 ARG A 151 SITE 2 AC2 5 CLR A 403 SITE 1 AC3 7 ILE A 55 THR A 73 CYS A 77 LEU A 80 SITE 2 AC3 7 ALA A 85 CLR A 402 HOH A 520 SITE 1 AC4 5 SER A 41 VAL A 129 PHE A 133 LEU A 144 SITE 2 AC4 5 LEU A 145 SITE 1 AC5 6 THR A 100 TYR A 132 PHE A 133 PHE A 217 SITE 2 AC5 6 VAL A 218 ARG A 221 SITE 1 AC6 5 PHE A 49 LEU A 53 GLN A 197 LEU A 339 SITE 2 AC6 5 HOH A 507 CRYST1 40.000 75.700 172.730 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025000 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013210 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005789 0.00000